In8Bio (INAB) Assets (2020 - 2026)

In8Bio has disclosed Assets across 7 years of filings, most recently posting $21.7 million for Q2 2026.

• In Q2 2026, Assets rose 12.26% year-over-year to $21.7 million; the TTM figure through Jun 2026 stood at $21.7 million (up 12.26% YoY), while the FY2025 annual figure was $32.3 million, up 54.13% from the prior year.
• Assets came in at $21.7 million for Q2 2026 at In8Bio, down from $26.3 million in the prior quarter.
• In the past five years, Assets ranged from a high of $38.4 million in Q3 2022 to a low of $16.0 million in Q3 2024.
• Average Assets over 5 years is $26.4 million, with a median of $26.2 million recorded in 2023.
• Year-over-year, Assets surged 76.43% in 2022 and plunged 39.08% in 2024.
• Over 5 years, Assets stood at $33.0 million in 2022, then climbed by 2.03% to $33.7 million in 2023, then slumped by 37.87% to $20.9 million in 2024, then surged by 54.13% to $32.3 million in 2025, then sank by 32.64% to $21.7 million in 2026.
• Per Business Quant data, the three most recent Assets figures were $21.7 million in Q2 2026, $26.3 million in Q1 2026, and $32.3 million in Q4 2025.